Cyrano Therapeutics' Partnership

Cyrano Therapeutics raised a round of funding on October 31, 2017. Investors include New Summit BioPharma.

Cyrano Therapeutics has developed an intranasal product to restore function in patients with a chronic loss of taste and smell.…

Articles about Cyrano Therapeutics' Partnership: